Laroxyl (Amitriptyline Hydrochloride)

Amitriptyline hydrochloride inhibits the reuptake of the neurotransmitters norepinephrine and serotonin at synaptic junctions, raising their levels in the central nervous system. This modulation enhances mood regulation, diminishes pain signaling, and stabilizes vascular tone, which underlies its antidepressant, analgesic, and migraine‑preventive actions.

The dosage of Laroxyl is individualized. A prescriber determines the appropriate strength, frequency, and duration based on the patient’s condition, age, response, and tolerance. Patients should follow the specific instructions provided by their healthcare professional and not adjust the dose on their own.

The safety of amitriptyline during pregnancy and lactation is not well established. Healthcare providers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives and precautions with their physician.

To request Laroxyl, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Laroxyl belongs to the tricyclic antidepressant class, which differs from selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs) in its broader receptor profile. It may be more effective for certain chronic pain conditions but often has a higher incidence of anticholinergic side effects compared with newer agents.

Laroxyl should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in their original packaging, protect them from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Laroxyl is taken orally, usually as a tablet, with or without food as directed by a prescriber. The exact timing (e.g., morning or bedtime) depends on the therapeutic goal and the patient’s tolerance to potential drowsiness.

Serious risks include cardiac arrhythmias, especially in patients with pre‑existing heart disease, seizures at high doses, severe hypotension, and rare cases of blood dyscrasias or hepatic toxicity. Prompt medical attention is required if any alarming symptoms develop.

Laroxyl is contraindicated in individuals with known hypersensitivity to amitriptyline or other tricyclic antidepressants, recent use of monoamine oxidase inhibitors, and patients with certain cardiac conduction disorders. It should also be used with caution in the elderly and those with severe hepatic impairment.